Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
38.60
-2.52 (-6.13%)
At close: Jan 13, 2026, 4:00 PM EST
39.00
+0.40 (1.04%)
After-hours: Jan 13, 2026, 6:05 PM EST
KNSA Market Cap
KNSA has a market cap or net worth of $2.93 billion as of January 13, 2026. Its market cap has increased by 101.50% in one year.
Market Cap
2.93B
Enterprise Value
2.58B
1-Year Change
101.50%
Ranking
Category
Stock Price
$38.60
Market Cap Chart
Since May 24, 2018, KNSA's market cap has increased from $943.14M to $2.93B, an increase of 210.21%. That is a compound annual growth rate of 15.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2026 | 2.93B | -6.42% |
| Dec 31, 2025 | 3.13B | 118.93% |
| Dec 31, 2024 | 1.43B | 15.76% |
| Dec 29, 2023 | 1.23B | 18.45% |
| Dec 30, 2022 | 1.04B | 28.46% |
| Dec 31, 2021 | 810.82M | -32.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 24, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 964.49B |
| Johnson & Johnson | 514.75B |
| AbbVie | 390.15B |
| UnitedHealth Group | 302.49B |
| AstraZeneca | 291.77B |
| Novartis AG | 272.12B |
| Merck & Co. | 268.70B |
| Novo Nordisk | 265.30B |